Quick Answer
Outset Medical, Inc. reported Research And Development Expense of $21.24 million for the year ending 2025.
- Outset Medical, Inc. showed a decrease of -44.7% in Research And Development Expense from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $5.71 million | Q1 2020: $5.84 million | Q2 2020: $6.05 million | Q3 2020: $9.18 million | Q1 2021: $7.57 million | Q2 2021: $8.03 million | Q3 2021: $9.73 million | Q1 2022: $10.83 million | Q2 2022: $13.52 million | Q3 2022: $13.06 million | Q1 2023: $13.79 million | Q2 2023: $14.91 million | Q3 2023: $16.08 million | Q1 2024: $12.64 million | Q2 2024: $9.73 million | Q3 2024: $8.14 million | Q1 2025: $5.52 million | Q2 2025: $5.29 million | Q3 2025: $5.38 million.
- Over the full 8 years of available data (2018 to 2025), Outset Medical, Inc.'s Research And Development Expense has declined by 7.3%.
- Historical annual values: Fiscal year 2025: $21.24 million | Fiscal year 2024: $38.40 million | Fiscal year 2023: $57.31 million | Fiscal year 2022: $48.86 million | Fiscal year 2021: $36.74 million | Fiscal year 2020: $28.85 million | Fiscal year 2019: $23.33 million | Fiscal year 2018: $22.92 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: